Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Hand Foot and Mouth Disease Limited Appeal For Pharmaceutical Investment

This article was originally published in PharmAsia News

Executive Summary

Since early this year, the spread of hand foot and mouth disease in China's Fuyang city and other areas has spurred the sales of domestic antiviral products, drawing the attention of venture capitalists. Several securities companies believe there are investment opportunities, sparking a rise in pharmaceutical shares in recent days. However, analysts caution that such spikes may have close relationship with the Sichuan earthquake. HFMD may drive sales in the short term but has limited impact since the disease is relatively easy to treat. (Click here for more - Chinese Language)



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts